CapsoVision, Inc Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
CapsoVision, Inc (CV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.05 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 1.79M shares, a 944.95% increase year-over-year.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 261.50K shares.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 277.00K shares.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 86.55K shares.
- CapsoVision, Inc share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 534.72K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.79M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 2.05M shares 10-Q · filed 2026-08-13 | 2.33M shares derived: sum of 3 quarters · filed 2026-08-13 | 2.41M shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 261.50K shares 10-Q · filed 2026-05-14 | 538.50K shares derived: sum of 2 quarters · filed 2026-05-14 | 625.05K shares derived: sum of 3 quarters · filed 2026-05-14 | 796.22K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 277.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 363.55K shares derived: sum of 2 quarters · filed 2026-03-26 | 534.72K shares derived: sum of 3 quarters · filed 2026-03-26 | 534.72K shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 86.55K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 257.72K shares derived: sum of 2 quarters · filed 2025-11-13 | 257.72K shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 171.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 171.17K shares 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-14 | |||
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-11-13 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |